202 related articles for article (PubMed ID: 23891150)
1. Structure-based design of covalent Siah inhibitors.
Stebbins JL; Santelli E; Feng Y; De SK; Purves A; Motamedchaboki K; Wu B; Ronai ZA; Liddington RC; Pellecchia M
Chem Biol; 2013 Aug; 20(8):973-82. PubMed ID: 23891150
[TBL] [Abstract][Full Text] [Related]
2. The substrate binding domains of human SIAH E3 ubiquitin ligases are now crystal clear.
Zhang Q; Wang Z; Hou F; Harding R; Huang X; Dong A; Walker JR; Tong Y
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3095-3105. PubMed ID: 27776223
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the substrate binding site of Siah ubiquitin ligase.
House CM; Hancock NC; Möller A; Cromer BA; Fedorov V; Bowtell DD; Parker MW; Polekhina G
Structure; 2006 Apr; 14(4):695-701. PubMed ID: 16615911
[TBL] [Abstract][Full Text] [Related]
4. Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling.
Polekhina G; House CM; Traficante N; Mackay JP; Relaix F; Sassoon DA; Parker MW; Bowtell DD
Nat Struct Biol; 2002 Jan; 9(1):68-75. PubMed ID: 11742346
[TBL] [Abstract][Full Text] [Related]
5. [Reduced expression of the E3-ubiquitin ligase seven in absentia homologue (SIAH)-1 in human hepatocellular carcinoma].
Brauckhoff A; Ehemann V; Schirmacher P; Breuhahn K
Verh Dtsch Ges Pathol; 2007; 91():269-77. PubMed ID: 18314624
[TBL] [Abstract][Full Text] [Related]
6. Phylogenetic analysis of the SINA/SIAH ubiquitin E3 ligase family in Metazoa.
Pepper IJ; Van Sciver RE; Tang AH
BMC Evol Biol; 2017 Aug; 17(1):182. PubMed ID: 28784114
[TBL] [Abstract][Full Text] [Related]
7. The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells.
Jumpertz S; Hennes T; Asare Y; Vervoorts J; Bernhagen J; Schütz AK
Cell Signal; 2014 Sep; 26(9):2051-9. PubMed ID: 24882689
[TBL] [Abstract][Full Text] [Related]
8. The SIAH E3 ubiquitin ligases promote Wnt/β-catenin signaling through mediating Wnt-induced Axin degradation.
Ji L; Jiang B; Jiang X; Charlat O; Chen A; Mickanin C; Bauer A; Xu W; Yan X; Cong F
Genes Dev; 2017 May; 31(9):904-915. PubMed ID: 28546513
[TBL] [Abstract][Full Text] [Related]
9. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K
J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256
[TBL] [Abstract][Full Text] [Related]
10. Rational modulator design by exploitation of protein-protein complex structures.
Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
[TBL] [Abstract][Full Text] [Related]
11. Siah proteins: novel drug targets in the Ras and hypoxia pathways.
House CM; Möller A; Bowtell DD
Cancer Res; 2009 Dec; 69(23):8835-8. PubMed ID: 19920190
[TBL] [Abstract][Full Text] [Related]
12. Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP.
Johansson H; Isabella Tsai YC; Fantom K; Chung CW; Kümper S; Martino L; Thomas DA; Eberl HC; Muelbaier M; House D; Rittinger K
J Am Chem Soc; 2019 Feb; 141(6):2703-2712. PubMed ID: 30657686
[TBL] [Abstract][Full Text] [Related]
13. Siah: a promising anticancer target.
Wong CS; Möller A
Cancer Res; 2013 Apr; 73(8):2400-6. PubMed ID: 23455005
[TBL] [Abstract][Full Text] [Related]
14. Converting One-Face α-Helix Mimetics into Amphiphilic α-Helix Mimetics as Potent Inhibitors of Protein-Protein Interactions.
Lee JH; Oh M; Kim HS; Lee H; Im W; Lim HS
ACS Comb Sci; 2016 Jan; 18(1):36-42. PubMed ID: 26651509
[TBL] [Abstract][Full Text] [Related]
15. Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling.
Bjij I; Ramharack P; Khan S; Cherqaoui D; Soliman MES
Molecules; 2019 Aug; 24(17):. PubMed ID: 31466292
[TBL] [Abstract][Full Text] [Related]
16. I Siah substrate!
Briant DJ; Ceccarelli DF; Sicheri F
Structure; 2006 Apr; 14(4):627-8. PubMed ID: 16615900
[TBL] [Abstract][Full Text] [Related]
17. Testing the Effects of SIAH Ubiquitin E3 Ligases on Lysine Acetyl Transferases.
Hagenbucher J; Stekman H; Rodriguez-Gil A; Kracht M; Schmitz ML
Methods Mol Biol; 2017; 1510():297-312. PubMed ID: 27761830
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation.
Avraham E; Szargel R; Eyal A; Rott R; Engelender S
J Biol Chem; 2005 Dec; 280(52):42877-86. PubMed ID: 16174773
[TBL] [Abstract][Full Text] [Related]
19. Proximity-enabled bioreactivity to generate covalent peptide inhibitors of p53-Mdm4.
Hoppmann C; Wang L
Chem Commun (Camb); 2016 Apr; 52(29):5140-3. PubMed ID: 26996321
[TBL] [Abstract][Full Text] [Related]
20. SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.
Buchwald M; Pietschmann K; Brand P; Günther A; Mahajan NP; Heinzel T; Krämer OH
Oncogene; 2013 Oct; 32(41):4913-20. PubMed ID: 23208506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]